XML 99 R83.htm IDEA: XBRL DOCUMENT v3.10.0.1
Related-Party Transactions - Additional Information (Details) - USD ($)
1 Months Ended 12 Months Ended
Oct. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Nov. 17, 2016
Related Party Transaction [Line Items]        
Service revenue   $ 21,503,894 $ 14,759,567  
Research and development   12,598,034 9,996,627  
Accounts receivable   5,012,678 6,356,268  
Profit sharing payments included in collaborative development services revenue   $ 5,090,475 $ 4,971,806  
Common stock, shares issued   28,585,449 13,929,763  
Common stock value   $ 28,585 $ 13,929  
Collaborative Development Services        
Related Party Transaction [Line Items]        
Service revenue   12,382,504 7,962,312  
SOW One        
Related Party Transaction [Line Items]        
Profit sharing payments included in collaborative development services revenue   99,394 1,272,080  
Research and development   1,716,115 2,129,138  
Accounts receivable   0 2,429,152  
SOW One | Collaborative Development Services        
Related Party Transaction [Line Items]        
Service revenue   2,297,742 2,604,892  
SOW Two        
Related Party Transaction [Line Items]        
Profit sharing payments included in collaborative development services revenue   1,779,827 1,072,130  
Research and development   3,625,332 2,645,825  
Accounts receivable   1,007,950 1,796,157  
Revenues   4,208,194 2,988,211  
SOW Two | Collaborative Development Services        
Related Party Transaction [Line Items]        
Service revenue   5,988,021 4,060,341  
SOW Three        
Related Party Transaction [Line Items]        
Research and development   2,667,030    
Accounts receivable   363,869 0  
Revenues   3,641,715 0  
Profit sharing payments included in collaborative development services revenue   355,631 0  
SOW Three | Collaborative Development Services        
Related Party Transaction [Line Items]        
Service revenue   $ 3,997,346    
QIAGEN Manchester Limited        
Related Party Transaction [Line Items]        
Agreement commencement period   2016-11    
Term of agreement   5 years    
Termination payment   $ 2,000,000    
QIAGEN Manchester Limited | Maximum        
Related Party Transaction [Line Items]        
Term of agreement   1 year    
QIAGEN North American Holdings, Inc.        
Related Party Transaction [Line Items]        
Revenues   $ 35,000 4,375  
Common stock, shares issued       833,333
Common stock value       $ 2,000,000
Deferred revenue   $ 175,000    
Deferred revenue recognition period   5 years    
QIAGEN North American Holdings, Inc. | Convertible Promissory Note        
Related Party Transaction [Line Items]        
Cash proceeds from issuance of subordinated notes $ 3,000,000      
Debt instrument, interest rate 3.00%      
Debt instrument, maturity date Oct. 26, 2020      
Conversion price per share $ 3.984      
Debt issuance costs   $ 25,787 40,510  
QIAGEN North American Holdings, Inc. | Convertible Promissory Note | Interest Expense        
Related Party Transaction [Line Items]        
Amortization of deferred financing costs   13,454 1,269  
Interest accrued   $ 90,000 $ 8,630  
QIAGEN North American Holdings, Inc. | Common Stock        
Related Party Transaction [Line Items]        
Shares issued price per share       $ 2.40